Franklin Strategic Series. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Jazz Pharmaceuticals plc | 5.66% | $65.33M | 258,371 |
| Amgen, Inc.AMGN | 4.39% | $50.67M | 131,554 |
| Gilead Sciences, Inc.GILD | 3.86% | $44.51M | 341,817 |
| Regeneron Pharmaceuticals, Inc.REGN | 3.77% | $43.48M | 57,013 |
| Argenx SEARGX | 3.62% | $41.80M | 48,962 |
| Vertex Pharmaceuticals, Inc.VRTX | 3.54% | $40.85M | 85,620 |
| Franklin Institutional U.S. Government Money Market FundCash or money market | 3.18% | $36.65M | 36,651,413 |
| Revolution Medicines, Inc.RVMD | 3.01% | $34.77M | 185,428 |
| Guardant Health, Inc.GH | 2.76% | $31.83M | 196,520 |
| Ascendis Pharma A/S | 2.56% | $29.58M | 121,287 |
| Dianthus Therapeutics, Inc.DNTH | 2.32% | $26.76M | 250,308 |
| Insmed, Inc.INSM | 1.99% | $22.98M | 233,052 |
| Mirum Pharmaceuticals, Inc.MIRM | 1.98% | $22.80M | 215,190 |
| Praxis Precision Medicines, Inc.PRAX | 1.91% | $22.10M | 71,799 |
| Spyre Therapeutics, Inc.SYRE | 1.87% | $21.63M | 220,000 |
| Oruka Therapeutics, Inc.ORKA | 1.86% | $21.46M | 222,393 |
| Neurocrine Biosciences, Inc.NBIX | 1.82% | $20.96M | 125,643 |
| Bridgebio Pharma, Inc.BBIO | 1.67% | $19.31M | 241,119 |
| PTC Therapeutics, Inc.PTCT | 1.65% | $19.02M | 279,737 |
| AstraZeneca plc | 1.51% | $17.39M | 102,531 |
| Franklin Institutional U.S. Government Money Market FundCash or money market | 1.45% | $16.70M | 16,697,193 |
| Amylyx Pharmaceuticals, Inc.AMLX | 1.32% | $15.29M | 752,824 |
| Eli Lilly & Co.LLY | 1.31% | $15.09M | 13,131 |
| Cytokinetics, Inc.CYTK | 1.24% | $14.35M | 186,018 |
| Tango Therapeutics, Inc.TNGX | 1.23% | $14.18M | 521,761 |
| EyePoint, Inc.EYPT | 1.19% | $13.76M | 1,123,495 |
| Abivax SAABVX | 1.18% | $13.62M | 109,022 |
| Mineralys Therapeutics, Inc.MLYS | 1.18% | $13.62M | 533,511 |
| Arcutis Biotherapeutics, Inc.ARQT | 1.18% | $13.58M | 505,651 |
| Indivior Pharmaceuticals, Inc.INDV | 1.15% | $13.30M | 332,496 |
| Thermo Fisher Scientific, Inc.TMO | 1.14% | $13.21M | 22,999 |
| Dyne Therapeutics, Inc.DYN | 1.13% | $13.07M | 519,232 |
| Bicara Therapeutics, Inc.BCAX | 1.11% | $12.87M | 474,899 |
| CG oncology, Inc.CGON | 1.08% | $12.42M | 174,532 |
| Benitec Biopharma, Inc.BNTC | 1.01% | $11.65M | 995,152 |
| Alkermes plc | 0.99% | $11.41M | 232,937 |
| Solid Biosciences, Inc.SLDB | 0.98% | $11.36M | 1,409,093 |
| Syndax Pharmaceuticals, Inc.SNDX | 0.96% | $11.10M | 582,815 |
| Ionis Pharmaceuticals, Inc.IONS | 0.94% | $10.84M | 209,423 |
| BeOne Medicines Ltd.ONC | 0.92% | $10.56M | 33,421 |
| Alnylam Pharmaceuticals, Inc.ALNY | 0.91% | $10.54M | 51,286 |
| Jade Biosciences, Inc.JBIO | 0.82% | $9.48M | 479,949 |
| Vaxcyte, Inc.PCVX | 0.68% | $7.88M | 145,674 |
| Xenon Pharmaceuticals, Inc.XENE | 0.67% | $7.76M | 123,767 |
| Relay Therapeutics, Inc.RLAY | 0.66% | $7.63M | 404,940 |
| ORIC Pharmaceuticals, Inc.ORIC | 0.63% | $7.30M | 659,005 |
| Neurogene, Inc.NGNE | 0.62% | $7.20M | 218,783 |
| Oruka Therapeutics, Inc.ORKA | 0.62% | $7.13M | 73,869 |
| Achieve Life Sciences, Inc.ACHV | 0.61% | $7.03M | 1,095,791 |
| BioNTech SEBNTX | 0.58% | $6.65M | 73,400 |